Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-23-000030 General Corporate
Debt relative to revenue 30th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.debt_to_revenue
294.25% · OPTIONAL · VALID
Capex intensity 12th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.82% · OPTIONAL · VALID
Operating cash generation 59th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
23.09% · OPTIONAL · VALID
Revenue growth 27th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
51.66% · CORE · VALID
Gross margin 11th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.gross_margin
77.40% · CORE · VALID
Operating margin 84th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.operating_margin
-16.83% · CORE · VALID
R&D intensity 53th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22.13% · OPTIONAL · VALID
SBC intensity 53th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
28.31% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 320.50%
Current 294.25%
Delta -26.25% Capex Intensity Decreased
Previous 7.09%
Current 4.82%
Delta -2.27% Cash Generation Decreased
Previous 36.13%
Current 23.09%
Delta -13.04% Growth Decreased
Previous 54.24%
Current 51.66%
Delta -2.58% Margin Decreased
Previous 78.43%
Current 77.40%
Delta -1.03% Profitability Increased
Previous -19.43%
Current -16.83%
Delta 2.60% R And D Intensity Increased
Previous 21.08%
Current 22.13%
Delta 1.05% Sbc Intensity Decreased
Previous 29.58%
Current 28.31%
Delta -1.27% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.